[2-(3-fluorophenyl)-6-hydroxynaphthalen-1-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride
C30H29ClFNO3 — CID 68950038
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-(3-fluorophenyl)-6-hydroxynaphthalen-1-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride
[2-(3-fluorophenyl)-6-hydroxynaphthalen-1-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride (PubChem CID 68950038) has the molecular formula C30H29ClFNO3 and a molecular weight of 506.02 g/mol. Its IUPAC name is [2-(3-fluorophenyl)-6-hydroxynaphthalen-1-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride.
Molecular Properties
| Compound Name | [2-(3-fluorophenyl)-6-hydroxynaphthalen-1-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride |
|---|---|
| PubChem CID | 68950038 |
| Molecular Formula | C30H29ClFNO3 |
| Molecular Weight | 506.02 g/mol |
| Exact Mass | 505.18 |
| IUPAC Name | [2-(3-fluorophenyl)-6-hydroxynaphthalen-1-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride |
| SMILES | Cl.O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2cccc(F)c2)ccc2cc(O)ccc12 |
| InChI | InChI=1S/C30H28FNO3.ClH/c31-24-6-4-5-22(19-24)27-13-9-23-20-25(33)10-14-28(23)29(27)30(34)21-7-11-26(12-8-21)35-18-17-32-15-2-1-3-16-32;/h4-14,19-20,33H,1-3,15-18H2;1H |
| InChIKey | XIIQQYSPJCMFLZ-UHFFFAOYSA-N |
| XLogP | 6.87 |
| TPSA | 49.77 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 506.02 |
| LogP ≤ 5 | 6.87 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 68950038 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.